Authors:
BAR FW
MEYER J
BOLAND J
BETRIU A
ARTMEYER B
CHARBONNIER B
MICHELS HR
TEBBE U
SPIECKER M
VERMEER F
VONFISENNE MJM
HOPKINS GR
BARTH H
Citation: Fw. Bar et al., BOLUS ADMINISTRATION OF SARUPLASE IN EUROPE (BASE), A PILOT-STUDY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Journal of thrombosis and thrombolysis, 6(2), 1998, pp. 147-153
Authors:
OPHUIS TJMO
BAR FW
JANSSEN WJ
VERMEER F
DASSEN WRM
WELLENS HJJ
Citation: Tjmo. Ophuis et al., ANGIOGRAPHIC VALIDATION OF BEDSIDE MARKERS OF CORONARY REPERFUSION INACUTE MYOCARDIAL-INFARCTION - CAN UNNECESSARY EMERGENCY ANGIOPLASTIESBY REDUCED - A PROSPECTIVE-STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 200-200
Authors:
VERMEER F
LANGENBERG M
HELLEMONS BS
LODDER J
SCHOUTEN H
VANREE JW
KNOTTNERUS JA
Citation: F. Vermeer et al., PRIMARY PREVENTION OF ARTERIAL THROMBOEMBOLISM IN NON-RHEUMATICAL ATRIAL-FIBRILLATION - RESULTS OF THE PATAF STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 344-345
Authors:
DENHEIJER P
VERMEER F
AMBROSIONI E
SADOWSKI Z
LOPEZSENDON JL
VONESSEN R
BEAUFILS P
THADANI U
ADGEY J
PIERARD L
BRINKER J
DAVIES RF
SMALLING RW
WALLENTIN L
CASPI A
PANGERL A
TRICKETT L
HAUCK C
HENRY D
CHEW P
Citation: P. Denheijer et al., EVALUATION OF A WEIGHT-ADJUSTED SINGLE-BOLUS PLASMINOGEN-ACTIVATOR INPATIENTS WITH MYOCARDIAL-INFARCTION - A DOUBLE-BLIND, RANDOMIZED ANGIOGRAPHIC TRIAL OF LANOTEPLASE VERSUS ALTEPLASE, Circulation, 98(20), 1998, pp. 2117-2125
Authors:
VERMEER F
VAHANIAN A
FELS PW
BESSE P
RADZIK D
SIMOONS ML
Citation: F. Vermeer et al., INTRAVENOUS ARGATROBAN VERSUS HEPARIN AS CO-MEDICATION TO ALTEPLASE IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - PRELIMINARY-RESULTS OF THE ARGAMI PILOT-STUDY, Journal of the American College of Cardiology, 29(2), 1997, pp. 7384-7384
Authors:
VERMEER F
WERTER C
VANDERBERG E
BOEHMER T
DASSEN W
KRIJNE R
VANOMMEN V
OPHUIS TO
BAR F
Citation: F. Vermeer et al., SAFETY AND FEASIBILITY OF RESCUE PTCA OR PRIMARY PTCA IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION ADMITTED TO A HOSPITAL WITHOUT PTCA FACILITIES, Journal of the American College of Cardiology, 29(2), 1997, pp. 7976-7976
Authors:
MAAS ACP
VANDOMBURG RT
VOS J
DECKERS JW
VERMEER F
REMME WJ
KAMP O
CATS VA
SIMOONS ML
Citation: Acp. Maas et al., 10 TO 14 YEAR FOLLOW-UP OF THE INTERUNIVERSITY CARDIOLOGY INSTITUTE TRIAL - IMPROVED LONG-TERM SURVIVAL IN ACUTE MYOCARDIAL-INFARCTION PATIENTS TREATED WITH EARLY THROMBOLYTIC THERAPY, Journal of the American College of Cardiology, 29(2), 1997, pp. 94814-94814
Authors:
VANDERWERF F
VAHANIAN A
GULBA DC
MULLER J
ARNOLD AER
BAR F
VERMEER F
VERHEUGT FWA
BOERSMA H
VANES GA
DECKERS JW
LENDERINK T
SIMOONS ML
STEYERBERG E
VANDERZWAAN C
DEBOER MJ
ZIJLSTRA F
WILCOX RD
SLEIGHT P
SELKER HP
CALIFF RM
GRANGER C
LEE KL
OHMAN ME
WEAVER DW
LOVE T
WHITE H
CALIFF R
COLLINS R
Citation: F. Vanderwerf et al., SELECTION OF REPERFUSION THERAPY FOR INDIVIDUAL PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION, European heart journal, 18(9), 1997, pp. 1371-1381
Citation: Jwmg. Widdershoven et al., CHANGING CHARACTERISTICS AND IN-HOSPITAL OUTCOME IN PATIENTS ADMITTEDWITH ACUTE MYOCARDIAL-INFARCTION - OBSERVATIONS FROM 1982 TO 1994, European heart journal, 18(7), 1997, pp. 1073-1080
Authors:
VERMEER F
TEBBE U
HOPKINS GR
WINDELER J
MICHELS RH
BAR FW
BARTH H
Citation: F. Vermeer et al., MORTALITY AND STROKE RISK AFTER TREATMENT WITH SARUPLASE - OBSERVATIONS IN 2509 PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Circulation, 96(8), 1997, pp. 1847-1847
Authors:
BAR FW
MEYER J
VERMEER F
MICHELS R
CHARBONNIER B
HAERTEN K
SPIECKER M
MACAYA C
HANSSEN M
HERAS M
BOLAND JP
MORICE MC
DUNN FG
UEBIS R
HAMM C
AYZENBERG O
STRUPP G
WITHAGEN AJ
KLEIN W
WINDELER J
HOPKINS G
BARTH H
VONFISENNE MJM
Citation: Fw. Bar et al., COMPARISON AT SARUPLASE AND ALTEPLASE IN ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 79(6), 1997, pp. 727-732
Authors:
LANGENBERG M
HELLEMONS BSP
VANREE JW
VERMEER F
LODDER J
SCHOUTEN HA
KNOTTNERUS JA
Citation: M. Langenberg et al., ATRIAL-FIBRILLATION IN ELDERLY PATIENTS - PREVALENCE AND COMORBIDITY IN GENERAL-PRACTICE, BMJ. British medical journal, 313(7071), 1996, pp. 1534-1534
Authors:
VERMEER F
HOPKINS GR
WINDELER J
TEBBE U
MICHELS RH
BAR FW
BARTH H
Citation: F. Vermeer et al., EFFICACY AND SAFETY DATA OF 4317 PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITHIN 6 HOURS AFTER ONSET WITH SARUPLASE, Circulation, 94(8), 1996, pp. 4356-4356
Authors:
BAR FW
VOLDERS PGA
HOPPENER P
VERMEER F
MEYER J
WELLENS HJJ
Citation: Fw. Bar et al., DEVELOPMENT OF ST-SEGMENT ELEVATION AND Q-WAVE AND R-WAVE CHANGES IN ACUTE MYOCARDIAL-INFARCTION AND THE INFLUENCE OF THROMBOLYTIC THERAPY, The American journal of cardiology, 77(5), 1996, pp. 337-343
Authors:
GORGELS APM
WIDDERSHOVEN JWMG
DEVREEDESWAGEMAKERS JJM
DIJKMAN LWN
ARBOUW W
VERMEER F
WELLENS HJJ
Citation: Apm. Gorgels et al., HAS THE LONG-TERM PROGNOSIS OF ACUTE MYOCARDIAL-INFARCTION IMPROVED WITH THE NEW TREATMENTS, European heart journal, 16, 1995, pp. 54-56
Authors:
DEZWAAN C
BAR FW
DASSEN WRM
VERMEER F
WELLENS HJJ
Citation: C. Dezwaan et al., CHANGES IN WALL-MOTION IN PATIENTS TREATED FOR UNSTABLE ANGINA - A SUGGESTION OF THE STUNNED AND HIBERNATING MYOCARDIUM IN HUMANS, Chest, 108(4), 1995, pp. 903-911
Authors:
BAR FW
RAYNAUD P
RENKIN JP
VERMEER F
DEZWAAN C
WELLENS HJJ
Citation: Fw. Bar et al., CORONARY ANGIOGRAPHIC FINDINGS DO NOT PREDICT CLINICAL OUTCOME IN PATIENTS WITH UNSTABLE ANGINA, Journal of the American College of Cardiology, 24(6), 1994, pp. 1453-1459
Authors:
VERMEER F
BAR FW
WINDELER J
HOPKINS GR
BARTH H
Citation: F. Vermeer et al., SARUPLASE - EFFICACY AND SAFETY DATA OF 2570 PATIENTS, Journal of the American College of Cardiology, 1994, pp. 10000345-10000345
Authors:
BAR FW
FREDERIKS J
DESWART H
VANOMMEN VG
GORGELS AP
DEZWAAN C
VERMEER F
WELLENS HJ
Citation: Fw. Bar et al., COMPARISON BETWEEN ACUTE PTCA AFTER FAILED THROMBOLYSIS AND IMMEDIATEPTCA WITHOUT THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 1994, pp. 10000405-10000405
Authors:
APPLEBY P
BAIGENT C
COLLINS R
FLATHER M
PARISH S
PETO R
BELL P
HALLS H
MEAD G
DIAZ R
PAOLASSO E
PAVIOTTI C
ROMERO G
CAMPBELL T
OROURKE MF
THOMPSON P
LESAFFRE E
VANDEWERF F
VERSTRAETE M
ARMSTRONG PW
CAIRNS JA
MORAN C
TURPIE AG
YUSUF S
GRANDE P
HEIKKILA J
KALA R
BASSAND JP
BOISSEL JP
BROCHIER M
LEIZOROVICZ A
BRUGGEMANN T
KARSCH KR
KASPER W
LAMMERTS D
NEUHAUS KL
MEYER J
SCHRODER R
VONESSEN R
SARAN RK
ARDISSINO D
BONADUCE D
BRUNELLI C
CERNIGLIARO C
FORESTI A
FRANZOSI MG
GUIDUCCI D
MAGGIONI A
MAGNANI B
MATTIOLI G
ROSSI P
SAONTRO E
TOGNONI G
VISANI L
ZENNARO RG
KANEMOTO N
KAWAI C
ARNOLD AER
BAR FW
SIMOONS ML
VERHEUGT FWA
VERMEER F
WHITE HD
SEABRAGOMES R
FIGUERAS J
LOPEZSENDON J
GRIP L
HERLITZ J
KARLSSON JE
WALLENTIN L
MONNIER P
ADAMS PC
BEEN M
CHAMBERLAIN DA
DEBONO D
DOLL R
DUFF D
FOX KAA
SREEHARAN N
HILLIS WS
JULIAN DG
MALCOLM A
MURRAY RG
PATTERSON DLH
POCOCK S
REID DS
SANDERCOCK P
SIGWART U
SKELDING J
SKENE A
SLEIGHT P
TIMMIS A
WARLOW C
WILCOX RG
ALLEN A
ANDERSON J
BRAUNWALD E
CALIFF R
GOLD HK
GRANETT J
GRAINGER C
GUERCI AD
HENNEKENS C
HONAN MB
KENNEDY JW
KNATTERUD G
LEE K
LEIMBERGER J
LENERT LA
LITTLEJOHN J
MAYNARD C
NICKLAS J
OHMAN M
OLSON HG
PASSAMANI E
RYAN TJ
SELKER HP
STUMP D
TOPOL EJ
WEAVER WD
WILLIAMS DO
WOODLIEF L
Citation: P. Appleby et al., INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS, Lancet, 343(8893), 1994, pp. 311-322
Authors:
HAMULYAK K
JIE KSG
SCHAUWAERT A
VERMEER F
Citation: K. Hamulyak et al., BLOOD-PLATELET AND PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) IN STABLE CORONARY-ARTERY DISEASE (CAD), Thrombosis and haemostasis, 69(6), 1993, pp. 813-813
Authors:
BAR FW
MEYER J
MICHELS R
UEBIS R
LANGE S
BARTH H
GROVES R
VERMEER F
Citation: Fw. Bar et al., THE EFFECT OF TAPROSTENE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTIONTREATED WITH THROMBOLYTIC THERAPY - RESULTS OF THE START STUDY, European heart journal, 14(8), 1993, pp. 1118-1126
Citation: F. Vermeer et al., SARUPLASE, A NEW FIBRIN SPECIFIC THROMBOLYTIC AGENT - FINAL RESULTS OF THE PASS STUDY (1698 PATIENTS), Circulation, 88(4), 1993, pp. 292-292
Citation: F. Vermeer et A. Vanderlaarse, CUMULATIVE ENZYME-RELEASE AS A MEASURE OF INFARCT SIZE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION RECEIVING THROMBOLYTIC THERAPY, Archives des maladies du coeur et des vaisseaux, 86, 1993, pp. 25-28